Sandoz Group AG
🇩🇪XFRA.D8Y0GermanyHealthcare
Price€75.00+0.50 (+0.67%)
Latest anomalies
Very negative 19 detected in the last 120 days
- High: 7
- Medium: 4
- Low: 7
Volume: a spike above the 20-day average
Volume: a spike above the 20-day average
Volume: a spike above the 20-day average
52-week high: the price is trading close to this level
Volume: a spike above the 20-day average
Free with a Finzer account.
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US7999261008
- CUSIP
- Not reported
Company
- Employees
- 20,000
- Headquarters
- Basel, Switzerland
- Website
- https://www.sandoz.com
Market
- Shares outstanding
- 432.7M
- Market cap
- €32.47B
Highlights
- Market cap
- €32.47B
- EPS LTM
- CHF 0.18
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- CHF 12.24B-9.88%down year on year
- Net income
- CHF 79.55M-90.98%down year on year
- Gross margin
- 45.63%-3.6%down year on year
- Free cash flow
- CHF 198M-79.94%down year on year
Latest news
News is not sourced for this exchange.
Business summary
Sandoz Group AG is a company in the healthcare sector, listed on Frankfurt Stock Exchange (Germany) under the ticker D8Y0. Its market capitalisation is €32.47B, from 432.7M shares outstanding, as of . Across the 252 trading sessions to the shares traded between €47.80 and €79.50, and the last close of €75.00 sits 86% of the way up that range. The company is headquartered in Basel, Switzerland, and employs about 20,000 people. This is the Frankfurt Stock Exchange listing of Sandoz Group AG; its primary listing is SDZ on SIX Swiss Exchange.
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.